Clinical guidelines for immunoglobulin a (IgA) nephropathy in Japan, second version

Clinical and Experimental Nephrology

Volumn 7, Issue 2, 2003, Pages 93-97

  Tomino, Yasuhiko ^a   Sakai, Hideto ^b  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOKAI UNIVERSITY   (Japan)

Author keywords

Clinical guidelines; IgA nephropathy; Second version

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CORTICOSTEROID; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; IMMUNOSUPPRESSIVE AGENT;

BLOOD PRESSURE; CLINICAL EXAMINATION; CLINICAL FEATURE; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIET THERAPY; DIFFERENTIAL DIAGNOSIS; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; JAPAN; PRACTICE GUIDELINE; PROGNOSIS; PROTEIN URINE LEVEL; REVIEW; TREATMENT PLANNING;

ADULT; CHILD; FEMALE; GLOMERULONEPHRITIS, IGA; HUMANS; JAPAN; KIDNEY; MALE; PROGNOSIS;

EID: 0042311243     PISSN: 13421751     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10157-003-0232-4     Document Type: Review

References (3)

1. Sakai H, Abe K, Kobayashi Y, Koyama A, Shigematsu H, Harada T, et al. Clinical guidelines of IgA nephropathy. Jpn J Nephrol 1995;37:417-21.
2. Berger J. IgA glomerular deposits in renal disease. Transplant Proc 1969;1:939-44.
3. Tomino Y. IgA nephropathy. From molecules to men. Basel: Karger; 1999.